Spermosens AB calls Extraordinary General Meeting

Spermosens AB (publ) has called its shareholders to an Extraordinary General Meeting to be held on Tuesday, September 1, 2026, at 10:00 a.m. at Medicon Village (The Spark) in Lund, Sweden.

Shareholders wishing to attend the meeting must be registered in the share register maintained by Euroclear Sweden AB as of Monday, August 24, 2026. Additionally, notification of participation must be submitted in writing to the company no later than Wednesday, August 26, 2026.

This meeting provides shareholders with an opportunity to participate in the company's decision-making processes and discuss matters concerning its operations. Details regarding the meeting's agenda are expected to be made available through the company's official communication channels.

Spermosens AB is focused on developing diagnostic tools. The purpose of the Extraordinary General Meeting is to address strategic and administrative issues that are relevant to the company's ongoing development and future direction.